• Info
  • Insider Ownership

Insider Trading & Ownership of Stuart Poulton

Location
Newton, MA
Summary
The estimated net worth of Stuart Poulton is at least $858,072 dollars as of 19 Feb 2026. Stuart Poulton is the EVP, Chief Development Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $858.1K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stuart Poulton
All Insider Reports
All Insider Reports

Notify me when Stuart Poulton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Stuart Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. EVP, Chief Development Officer $858,072 -$6,675 -0.77% 17 Feb 2026

Insider Transactions Reported by Stuart Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.